- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
UPDATE: CMS will Re-examine ICD-10 Timeline, Tavenner Says
After speaking to attendees at the American Medical Association Advocacy Conference in Washington, acting CMS Administrator Marilyn Tavenner told reporters that the CMS will "re-examine the timeframe" through a rulemaking process. She did not say when that rulemaking process will begin but said the CMS would send details about the process in the coming days.
"There’s concern that folks cannot get their work done around meaningful use, their work around ICD-10 implementation and be ready for exchanges," Tavenner said. "So we’re trying to listen to that and be responsive."
Source: Modern Healthcare
Separately, Tavenner said she the CMS has had "good results" with accountable care organization applications and expects to make an announcement about selected applicants "at the beginning of the second quarter of this year."
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
